Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality

International Journal of Cardiology

Volumn 184, Issue 1, 2015, Pages 512-513

  Yildiz, Ali ^a   Soydinc, Serdar ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Atrial fibrillation; Cardiovascular mortality; Digoxin; Heart failure; Mortality

Indexed keywords

DIGOXIN; ANTICOAGULANT AGENT;

AGE DISTRIBUTION; ANOREXIA; ATRIAL FIBRILLATION; BODY MASS; CARDIOVASCULAR MORTALITY; COMORBIDITY; DOSE RESPONSE; DRUG INDICATION; ELECTROLYTE DISTURBANCE; FUNCTIONAL STATUS; HEART FAILURE; HEART RATE; HUMAN; KIDNEY DYSFUNCTION; LETTER; NAUSEA; NEUROLOGIC DISEASE; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION; VOMITING; CEREBROVASCULAR ACCIDENT; FEMALE; MALE; MORTALITY;

ANTICOAGULANTS; ATRIAL FIBRILLATION; DIGOXIN; FEMALE; HEART FAILURE; HUMANS; MALE; RISK ASSESSMENT; STROKE;

EID: 84929366059     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.03.029     Document Type: Article

References (11)

1. D. Pastori, A. Farcomeni, T. Bucci, R. Cangemi, P. Ciacci, T. Vicario, et al., Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation, Int. J. Cardiol. 180 (Feb 1 2015) 1-5. http://dx.doi.org/10.1016/j.ijcard.2014.11.112 (Epub 2014 Nov 18).
2. K.F. Jr Adams, J.H. Patterson, W.A. Gattis, C.M. O'Connor, C.R. Lee, T.A. Schwartz, et al., Relationship of serum digoxin concentration to mortality and morbidity in women in the Digitalis Investigation Group trial: a retrospective analysis, J. Am. Coll. Cardiol. 46 (2005) 497-504. http://dx.doi.org/10.1016/j.jacc.2005.02.091.
3. J.A. Ingelfinger, P. Goldman, The serum digitalis concentration: does it diagnose digitalis toxicity? N. Engl. J. Med. 294 (1976) 867-870. http://dx.doi.org/10.1056/NEJM197604152941603.
4. D.N. Juurlink, M. Mamdani, A. Kopp, A. Laupacis, D.A. Redelmeier, Drug-drug interactions among elderly patients hospitalized for drug toxicity, JAMA 289 (2003) 1652-1658. http://dx.doi.org/10.1001/jama.289.13.1652.
5. W.D. Hager, P. Fenster, M. Mayersohn, D. Perrier, P. Graves, F.I. Marcus, et al., Digox-in-quinidine interaction: pharmacokinetic evaluation, N. Engl. J. Med. (1979) 1238-1241. http://dx.doi.org/10.1056/NEJM197905313002202.
6. E.D. Bizjak, V.F. Mauro, Digoxin-macrolide drug interaction, Ann. Pharmacother. 31 (1997) 1077-1079.
7. P. Hallberg, J. Lindback, B. Lindahl, U. Stenestrand, H. Melhus, Digoxin and mortality in atrial fibrillation: a prospective cohort study, Eur. J. Clin. Pharmacol. 63 (2007) 959-971. http://dx.doi.org/10.1007/s00228-007-0346-9.
8. J.J.V. McMurray, S. Adamopoulos, S.D. Anker, A. Auricchio, M. Böhm, K. Dickstein, ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC, Eur. Heart J. 33 (2012) (2012) 1787-1847. http://dx.doi.org/10.1093/eurheartj/ehs104.
9. C.W. Yancy, M. Jessup, B. Bozkurt, J. Butler, D.E. Jr Casey, M.H. Drazner, American College of Cardiology Foundation, American Heart Association Task Force on Practice Guidelines, et al., 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J. Am. Coll. Cardiol. 62 (2013) e147-e239. http://dx.doi.org/10.1016/j.jacc.2013.05.019.
10. A.J. Camm, P. Kirchhof, G.Y. Lip, U. Schotten, I. Savelieva, S. Ernst, European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC), Eur. Heart J. 31 (2010) 2369-2429. http://dx.doi.org/10.1093/eurheartj/ehq278.
11. C.T. January, L.S. Wann, J.S. Alpert, H. Calkins, J.E. Cigarroa, J.C. Cleveland Jr., ACC/AHA Task Force Members, 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines and the Heart Rhythm Society, Circulation 130 (2014) e199-e267. http://dx.doi.org/10.1161/CIR.0000000000000041.